Middle East & Africa Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion), By Stage Type, By Indication, By Sales Channel, And Segment Forecasts, 2024

Description

Middle East & Africa Parenteral Nutrition Market Growth & Trends:

The Middle East & Africa parenteral nutrition market size is expected to reach USD 346.0 million by 2030, registering a CAGR of 4.4%, according to a new report by Grand View Research, Inc. The MEA parenteral nutrition market is expected to witness lucrative growth over the forecast period owing to various parameters such as presence of large pool of malnourished children, rising premature births, increasing adoption by healthcare settings for nutrient administration in chronically ill geriatric patients, and rising prevalence rate of cancer within the region.

Increasing prevalence of chronic conditions such as cancer unswervingly influences the use of parenteral nutrition across the globe. Parenteral nutrition helps in the administration of key vital nutrients that are useful in maintaining strength, energy, and hydration level in cancer patients, thus, acting a vital impact rendering driver expected to surge market growth over the forecast period.

Similarly, predominant existence of malnourished children and premature neonates that require these nutrients, is expected to further propel the growth. According to statistics published by the Knoema, a public data platform, the prevalence of the malnutrition in Middle East and North Africa in 2013 was around 6.04%, however, it has witnessed a decline over the period of time.

Middle East & Africa Parenteral Nutrition Market Report Highlights:

Single dose amino acid solutions held a dominant share in 2023. This dominance is governed by the influx of innovative products. In addition, these innovative formulations are more efficient and cause lesser adverse effects.
Intravenous lipid emulsions are anticipated to witness lucrative growth over the forecast period. Drug delivery through lipid emulsion is expected to showcase promising results as it results in minimal adverse effects such as irritation, pain, and thrombophlebitis.
Adults dominated the market and accounted for 85.9% in 2023. The compromised gastrointestinal function, prolonged malnutrition, and increased malnutrition in adults drive the segmental growth.
Cancer care dominated the market and accounted for a market share of 16.9% in 2023. It can be attributed to the rising cancer cases in the Middle East and African region.
Institutional sales channels dominated the market and accounted for a market share of 49.2% in 2023. The large share of the segment can be attributed to the increasing allowance for the adoption of technologically advanced medical devices and parenteral nutrition solutions in settings such as hospitals and clinics.

Product Code: GVR-1-68038-838-1

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. MEA Parenteral Nutrition Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. MEA Parenteral Nutrition Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. MEA Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. MEA Parenteral Nutrition Market: Nutrient Type Movement Analysis, USD Million, 2023 & 2030
4.3. Carbohydrates
- 4.3.1. Carbohydrates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Parenteral Lipid Emulsion
- 4.4.1. Parenteral Lipid Emulsion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Single Dose Amino Acid Solution
- 4.5.1. Single Dose Amino Acid Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Trace Elements
- 4.6.1. Trace Elements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Vitamins & Minerals
- 4.7.1. Vitamins & Minerals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. MEA Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. MEA Parenteral Nutrition Market: Stage Type Movement Analysis, USD Million, 2023 & 2030
5.3. Adult
- 5.3.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Pediatric
- 5.4.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. MEA Parenteral Nutrition Market: Indication Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. MEA Parenteral Nutrition Market: Indication Movement Analysis, USD Million, 2023 & 2030
6.3. Alzheimer's
- 6.3.1. Alzheimer's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Nutrition Deficiency
- 6.4.1. Nutrition Deficiency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Cancer Care
- 6.5.1. Cancer Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Diabetes
- 6.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Chronic Kidney Diseases
- 6.7.1. Chronic Kidney Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Orphan Diseases
- 6.8.1. Orphan Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Dysphagia
- 6.9.1. Dysphagia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Pain Management
- 6.10.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Malabsorption/GI Disorder/Diarrhea
- 6.11.1. Malabsorption/GI Disorder/Diarrhea Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.12. Others
- 6.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. MEA Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. MEA Parenteral Nutrition Market: Sales Channel Movement Analysis, USD Million, 2023 & 2030
7.3. Online Sales Channel
- 7.3.1. Online Sales Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Retail Sales Channel
- 7.4.1. Retail Sales Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Institutional Sales Channel
- 7.5.1. Institutional Sales Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. MEA Parenteral Nutrition Market: Regional Estimates & Trend Analysis

8.1. MEA Parenteral Nutrition Market Share, By Region, 2023 & 2030, USD Million
8.2. Middle East and Africa
- 8.2.1. Middle East and Africa Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.2. South Africa
  - 8.2.2.1. South Africa Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.3. Saudi Arabia
  - 8.2.3.1. Saudi Arabia Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.4. UAE
  - 8.2.4.1. UAE Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.2.5. Kuwait
  - 8.2.5.1. Kuwait Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
- 9.4.1. B. Braun Melsungen AG
  - 9.4.1.1. Participant's Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Recent Developments/ Strategic Initiatives
- 9.4.2. Baxter
  - 9.4.2.1. Participant's Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Recent Developments/ Strategic Initiatives
- 9.4.3. Fresenius Kabi AG
  - 9.4.3.1. Participant's Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Recent Developments/ Strategic Initiatives
- 9.4.4. Qatar Pharma Factory
  - 9.4.4.1. Participant's Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Recent Developments/ Strategic Initiatives
- 9.4.5. Pfizer Inc.
  - 9.4.5.1. Participant's Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Recent Developments/ Strategic Initiatives
- 9.4.6. Evonik
  - 9.4.6.1. Participant's Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Recent Developments/ Strategic Initiatives

Middle East & Africa Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion), By Stage Type, By Indication, By Sales Channel, And Segment Forecasts, 2024 - 2030